Zobrazeno 1 - 10
of 201
pro vyhledávání: '"C, Schudt"'
Autor:
M-J, Sanz, J, Cortijo, M A, Taha, M, Cerdá-Nicolás, E, Schatton, B, Burgbacher, J, Klar, H, Tenor, C, Schudt, A C, Issekutz, A, Hatzelmann, E J, Morcillo
Publikováno v:
British journal of pharmacology. 152(4)
The present study addressed the effects of the investigational PDE4 inhibitor roflumilast on leukocyte-endothelial cell interactions and endothelial permeability in vivo and in vitro.In vivo, intravital video-microscopy was used to determine effects
Autor:
A, Hatzelmann, C, Schudt
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 297(1)
From a series of benzamide derivatives, roflumilast (3-cyclo-propylmethoxy-4-difluoromethoxy-N-[3,5-di-chloropyrid-4-yl]-benzamide) was identified as a potent and selective PDE4 inhibitor. It inhibits PDE4 activity from human neutrophils with an IC(5
Autor:
R T, Schermuly, A, Roehl, N, Weissmann, H A, Ghofrani, C, Schudt, H, Tenor, F, Grimminger, W, Seeger, D, Walmrath
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 292(2)
Aerosolized prostacyclin (PGI(2)) has been suggested for selective pulmonary vasodilation, but its effect rapidly levels off after termination of nebulization. Stabilization of the second-messenger cAMP by phosphodiesterase (PDE) inhibition may offer
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 283(3)
Exposure of perfused rat lungs to lipopolysaccharides (LPS) causes induction of cyclooxygenase-2 followed by thromboxane (TX)-mediated bronchoconstriction (BC). Recently, phosphodiesterase (PDE) inhibitors have received much interest because they not
Publikováno v:
British journal of pharmacology. 121(2)
1. During in vitro culture in 10% human AB serum, human peripheral blood monocytes acquire a macrophage-like phenotype. The underlying differentiation was characterized by increased activities of the macrophage marker enzymes unspecific esterase (NaF
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 280(1)
Injection of the T cell mitogens concanavalin A (Con A) into nonsensitized or of staphylococcal enterotoxin B (SEB) into D-galactosamine (GalN)-sensitized mice is known to cause fulminant liver failure via a cytokine response syndrome with tumor necr
Publikováno v:
European journal of pharmacology. 298(3)
The present study was designed to characterize the effects of unselective and isoenzyme-selective phosphodiesterase inhibitors on airway mucus secretion. The isolated rat trachea was incubated in a modified Ussing chamber. Mucus macromolecules were m
Publikováno v:
Wiener medizinische Wochenschrift (1946). 145(17-18)
An increased activity of the cAMP-degrading enzyme phosphodiesterase (PDE) has been observed in peripheral leukocytes from atopic patients. We studied 9 patients with seasonal allergic rhinoconjunctivitis and 9 controls during (summer) and out of sym
Publikováno v:
The American journal of physiology. 266(5 Pt 1)
The effects of the nonselective phosphodiesterase (PDE) inhibitor 3-isobutyl-1-methylxanthine (IBMX) and the selective PDE inhibitors motapizone (type III), rolipram (type IV), zardaverine (type III/IV), and zaprinast (type V and I) on prostaglandin